These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum AFP, hCG and CEA in the management of patients with testicular, ovarian and extragonadal germ cell tumors. Motawy MS; Szymendera JJ; al-Jazzaf H; Behbehani AE; Foudeh MO; Ebraheem AK; Nasralla MY; Ali MA Int J Biol Markers; 1992; 7(2):80-6. PubMed ID: 1378875 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors. Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A Oncology; 1983; 40(1):1-10. PubMed ID: 6185897 [TBL] [Abstract][Full Text] [Related]
4. Alphafetoprotein and germ cell neoplasms. Hayatnagarkar NP; Deshpande AD; Solanki BR Indian J Med Res; 1980 Aug; 72():269-72. PubMed ID: 6164638 [No Abstract] [Full Text] [Related]
5. Non-seminomatous germ cell tumors of the testis. Analysis of CEA production in primary tumors and in retroperitoneal lymph node metastases after PVB chemotherapy. Suurmeijer AJ; Oosterhuis JW; Marrink J; Ockhuizen T; Sleijfer DT; Schraffordt Koops H; Fleuren GJ Eur J Cancer Clin Oncol; 1984 May; 20(5):601-8. PubMed ID: 6203752 [TBL] [Abstract][Full Text] [Related]
6. Alpha-foetoprotein and carcinoembryonic antigen in germ cell neoplasms. Talerman A; van der Pompe WB; Haije WG; Baggerman L; Boekestein-Tjahjadi HM Br J Cancer; 1977 Mar; 35(3):288-91. PubMed ID: 66925 [TBL] [Abstract][Full Text] [Related]
7. [Tumor markers in germ cell tumors. Clinical use and research aspects]. Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594 [No Abstract] [Full Text] [Related]
8. [Evaluation of serum AFP, HCG, and CEA in testicular tumor]. Miki T; Oda H; Kamei O; Saiki S; Kinouchi T; Kuroda M; Yoshida M; Kiyohara H; Usami M; Osafune M Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1236-47. PubMed ID: 6198548 [No Abstract] [Full Text] [Related]
9. [Evaluation of plasma tumor markers in germinal tumors of the testis]. Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755 [TBL] [Abstract][Full Text] [Related]
10. Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors. Yamamoto H; Rudén U; Esposti P; Hirano K; Stigbrand T; Andersson L; Hisazumi H; Wahren B Urol Res; 1988; 16(1):31-6. PubMed ID: 2449757 [TBL] [Abstract][Full Text] [Related]
11. The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms. Ballas M Ann Clin Lab Sci; 1974; 4(4):267-75. PubMed ID: 4142543 [TBL] [Abstract][Full Text] [Related]
12. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary. Altaras MM; Goldberg GL; Levin W; Darge L; Bloch B; Smith JA Gynecol Oncol; 1986 Oct; 25(2):150-9. PubMed ID: 2428701 [TBL] [Abstract][Full Text] [Related]
13. Alpha-1 antitrypsin (AAT) and alphafoetoprotein (AFP) in sera of patients with germ-cell neoplasms: value as tumour markers in patients with endodermal sinus tumour (yolk sac tumour). Talerman A; Haije WG; Baggerman L Int J Cancer; 1977 Jun; 19(6):741-6. PubMed ID: 68937 [TBL] [Abstract][Full Text] [Related]
14. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours. Dieckmann KP; Hennig F; Anheuser P; Gehrckens R; Viehweger F; Wülfing C; Belge G Urol Int; 2021; 105(1-2):21-26. PubMed ID: 33049748 [TBL] [Abstract][Full Text] [Related]
15. Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours? McAleer JJ; Nicholls J; Horwich A Eur J Cancer; 1992; 28A(4-5):825-8. PubMed ID: 1381929 [TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugs. Khoo SK; MacKay EV Br J Obstet Gynaecol; 1976 Oct; 83(10):753-9. PubMed ID: 990213 [TBL] [Abstract][Full Text] [Related]
18. Placental alkaline phosphatase, alphafetoprotein and carcinoembryonic antigen in testicular tumors. Tissue typing by means of cytologic smears. Wahren B; Holmgren PA; Stigbrand T Int J Cancer; 1979 Dec; 24(6):749-53. PubMed ID: 94592 [TBL] [Abstract][Full Text] [Related]
19. The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma. Samaan NA; Smith JP; Rutledge FN; Schultz PN Am J Obstet Gynecol; 1976 Sep; 126(2):186-9. PubMed ID: 183504 [TBL] [Abstract][Full Text] [Related]
20. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases. Balzer BL; Ulbright TM Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]